fbpx

Research made for YOU

Research gives us the opportunity to learn more about ourselves and our world. By participating in research, you are helping further knowledge that impacts generations to come.

Research in the News

Remdesivir proves effective against COVID-19 in NIAID human clinical trials

Read on UNC News

The Baric Lab at UNC Gillings School of Public Health, in partnership with Gilead Sciences, has found that Remdesivir has been effective in treating patients with COVID-19. 

A new antiviral drug heading into clinical trials offers hope for COVID-19 treatment — in part because it can be taken as a pill

Read on Gillings School News

A drug called EIDD-2801 has shown positive outcomes on lung function in mice when used as a prophylactic and as a treatment during infection. 

Participant Spotlight

  • "If it sounds like something you're willing to do, and you want to advance science, do it."

    - Bruce, Healthy Volunteer

  • "He had a great time, he was laughing, he was really happy."

    - Desiree, mother of Sijuan

  • "Without research, lives could be lost. I think lives will be saved." 

    - Brenda, Volunteer

    Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

    Questions?

    • This email address is being protected from spambots. You need JavaScript enabled to view it.